565

A PROSPECTIVE STUDY OF ANTIBIOTIC USE IN CHILDHOOD AND RISK OF ADULT-ONSET COLORECTAL CANCER

Date
May 19, 2024

Background: Incidence rates of colorectal cancer (CRC) have increased among persons born in and after the 1960s, implicating risk factors in early life. We examined the impact of antibiotic use during childhood on risk of CRC in adult offspring of the Child Health and Development Studies (CHDS), a multi-generational cohort followed prospectively for more than 60 years.

Methods: Established in 1959, the CHDS enrolled nearly all pregnant women receiving care from the Kaiser Foundation Health Plan (Oakland, CA and surrounding East Bay) between June 1959 and September 1966, with deliveries through June 1967. Prescribed antibiotics (oral or injection) were abstracted from offspring’s medical records from birth through age five years, including the date and indicating condition. Incident diagnoses of CRC in adult offspring were ascertained through 2021 by linkage with the California Cancer Registry; we identified matched controls for each case (3:1) by randomly selecting offspring without CRC from strata of sex and birth year. We used conditional logistic regression models to estimate odds ratios (OR) for associations with antibiotic use (none vs. any) and number of prescribed antibiotics (< vs. > 90th percentile).

Results: We identified 51 adult offspring diagnosed with CRC (diagnosed at ages 23 – 59 years; 33.3% non-Hispanic Black) and 153 sex- and birth year-matched controls. By age two years, 90.4% of cases were prescribed at least one antibiotic (mean 3.7 0, range 0 – 19) compared to 73.2% of controls (mean 3.1, range 0 – 16). This difference narrowed by age five years: 94.1% of cases were prescribed at least one antibiotic (mean 6.4, range 0 – 27) compared to 80.4% of controls (mean 6.2, range 0 – 31). The most commonly prescribed antibiotics were Bicillin CR (penicillin G benzathine / penicillin G procaine, 14.2%), Gantrisin (acetyl sulfisoxazole, 13.6%), and tetracycline (7.7%). Any antibiotic use by age two years was associated with CRC in adulthood (OR 3.32, 95% CI 1.24, 8.93), and the magnitude of the association increased with the number of prescribed antibiotics (> 90th percentile: OR 4.43, 95% CI 1.25, 15.73). Associations persisted through age five years and were robust to adjustment for maternal race, maternal body mass index, and birth weight.

Conclusions: Our results suggest that antibiotic use during childhood is a risk factor for CRC, likely mediated by alterations in gut microbiota. Interventions addressing antibiotic stewardship in early life may be important to reduce the future burden of CRC, particularly among younger adults.

Presenter

Speaker Image for Caitlin Murphy
The University of Texas Health Science Center at Houston School of Public Health

Tracks

Related Products

Thumbnail for EXPECTED 10-YEAR MORTALITY IS NOT ASSOCIATED WITH COLORECTAL CANCER SCREENING
EXPECTED 10-YEAR MORTALITY IS NOT ASSOCIATED WITH COLORECTAL CANCER SCREENING
BACKGROUND: Health status and expected mortality are important considerations in assessing the benefits of colorectal cancer (CRC) screening, particularly for older adults given that CRC screening is recommended for adults with life expectancy ≥10 years…
Thumbnail for RISK PREDICTION FOR COLORECTAL CANCER USING QUANTITATIVE FECAL IMMUNOCHEMICAL TEST RESULTS — A STATISTICAL SOLUTION TO THE COLONOSCOPY CAPACITY ISSUE
RISK PREDICTION FOR COLORECTAL CANCER USING QUANTITATIVE FECAL IMMUNOCHEMICAL TEST RESULTS — A STATISTICAL SOLUTION TO THE COLONOSCOPY CAPACITY ISSUE
Colorectal cancer (CRC) is the third leading cause of cancer-related death in the United States. CRC screening can reduce mortality by removal of precancerous lesions during colonoscopy and increasing detection of CRC at an early stage…
Thumbnail for SERUM BIOMARKER SIGNATURE IS PREDICTIVE OF THE RISK OF HEPATOCELLULAR CANCER IN PATIENTS WITH CIRRHOSIS
SERUM BIOMARKER SIGNATURE IS PREDICTIVE OF THE RISK OF HEPATOCELLULAR CANCER IN PATIENTS WITH CIRRHOSIS
BACKGROUND. Several inflammatory and metabolic biomarkers have been associated with hepatocellular carcinoma (HCC) risk in phase I and II biomarker studies but not in longitudinal studies…